Mesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript – Yahoo Finance

For chronic inflammatory low back pain Rexlemestrocel has completed a first Phase 3 trial. We've received our RMAT designation from the FDA for this …
Source: back pain